|Articles|February 1, 2004

Antigen assay to detect pneumococcal infection: Is it good enough?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

The unharmonious 2026 child and adolescent immunization schedule - addendum | Image Credit: © kamon_saejueng

The unharmonious 2026 child and adolescent immunization schedule - addendum

ByJoudeh B. Freij, MD, ScM,Bishara J. Freij, MD

September 4th 2026

The unharmonious 2026 child and adolescent immunization schedule | Image Credit: ©pingpao - stock.adobe.com.

The unharmonious 2026 child and adolescent immunization schedule

ByJoudeh B. Freij, MD, ScM,Bishara J. Freij, MD

September 4th 2026

Evidence review supports respiratory virus immunizations for 2026-2027 season

Evidence review supports respiratory virus immunizations for 2026-2027 season

ByKevin Ault, MD, FACOG

September 3rd 2026

HPV vaccination coverage stalls for fourth straight year as rural-urban gap persists, CDC finds | Image Credit: © Halfpoint - stock.adobe.com

HPV vaccination coverage stalls for fourth straight year as rural-urban gap persists, CDC finds

ByMorgan Ebert, Executive Editor

September 3rd 2026

AAP recommends 2026-2027 COVID-19 vaccine for all infants 6 to 23 months and at-risk older children | Image Credit: © Jacob Lund - stock.adobe.com

AAP recommends 2026-2027 COVID-19 vaccine for all infants 6 to 23 months and at-risk older children

ByMorgan Ebert, Executive Editor

September 2nd 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

AAP expands RSV immunization recommendations for high-risk children

FDA approves zilganersen (Zanvastro) as first treatment for Alexander disease

The unharmonious 2026 child and adolescent immunization schedule - addendum

HPV vaccination coverage stalls for fourth straight year as rural-urban gap persists, CDC finds

Top 5 pediatric health headlines you missed in August 2026